Mass Spectrometry & Spectroscopy
New Released N-Glycan Assay Introduced
Jul 12 2016
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, have announced the launched of a new Released N-Glycan Assay for the in-depth profiling of IgG glycosylation. This new physico-chemical assay, developed by SSB’s subsidiary BioOutsource and offered in combination with its unique Antibody Dependent Cell Cytotoxicity (ADCC) assay platform, combines data on the molecular structure with a key therapeutic mechanism of action. This will generate comprehensive, highly accurate biosimilar comparability data, driving shorter drug development timelines.
The new N-Glycan Assay is one of a range of orthogonal methods, including analysis by CD16a (FcγRIIIa) and SPR binding, as well as ADCC functional assays that BioOutsource offers to provide a detailed testing package to generate evidence suitable for regulatory submissions.
BioOutsource’s new assay involves enzymatically-removing glycans from the antibody, functionally derivatising them and separating the glycans by UHPLC. The glycans are then identified by on-line electrospray ionisation mass spectrometry (ESI-MS), enabling confident assignment and precise quantification of the different structures.
Dr Daniel Galbraith, Chief Scientific Officer at Sartorius Stedim BioOutsource, explained: “The structural classification and monosaccharide composition of carbohydrates attached to the constant region of therapeutic biosimilar antibodies is key to their binding. An accurate understanding of these glycans ensures effective selection of biosimilars that have the optimum ADCC activity to destroy tumour cells.”
Galbraith continued: “Our new Released N-Glycan Assay coupled with our ADCC assays will help deliver this understanding by providing robust biosimilar characterisation data suitable for the regulators, thus enabling efficient drug development and more rapid entry into clinical programs.”
To find out about BioOutsource’s new Released N-Glycan Assay and complementary ADCC assays, scientists should go to www.biooutsource.com/glycan-analysis/.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark